A leading hospital in Hyderabad has launched a genetic testing service aimed at helping doctors determine the most effective medications for individual patients. This innovative approach promises to enhance personalized treatment by analyzing patients’ genetic makeup to predict drug response.
Hyderabad hospital launches genetic testing to help doctors personalize medication, improving treatment effectiveness by analyzing patients’ genetic makeup.
Hyderabad, October 23, 2025 – A pioneering hospital in Hyderabad has introduced a new genetic testing service designed to assist physicians in identifying which medicines will work best for their patients. This advancement in medical technology aims to personalize treatment plans by analyzing a patient’s genetic profile, ushering in a new era of precision medicine in the region.
The service, launched this week at the hospital’s state-of-the-art facility, offers a pharmacogenetic test that examines specific genes responsible for how individuals metabolize and respond to a range of medications. By understanding variations in these genes, doctors can make more informed decisions regarding drug selection and dosage, potentially reducing adverse drug reactions and improving therapeutic outcomes.
According to hospital officials, this initiative addresses a critical challenge in healthcare: the variability in patient responses to standard drug therapies. “No two patients are the same, and genetic factors play a significant role in how medicines behave in the body,” said Dr. Anil Kumar, head of the hospital’s clinical genomics department. “With this genetic test, we can tailor treatments to the individual’s unique genetic makeup, increasing the efficacy and safety of prescribed medications.”
Pharmacogenomics, the study of how genes affect a person’s response to drugs, has gained momentum globally as a tool for optimizing drug therapy. However, accessibility to such testing has been limited in many parts of India due to cost and availability. The hospital’s new offering seeks to bridge this gap by providing affordable and timely genetic testing services to patients in Hyderabad and surrounding regions.
The testing process involves collecting a blood or saliva sample from the patient, followed by DNA extraction and analysis in a specialized laboratory. Results typically identify gene variants that influence drug metabolism enzymes and receptors. Physicians then use the test report to adjust drug type or dosage accordingly.
For example, patients with certain gene variants might require lower doses of anticoagulants or alternative medications to avoid adverse effects. The hospital’s genetic test covers a broad spectrum of drug categories, including cardiovascular drugs, antidepressants, antiepileptics, and chemotherapy agents.
Patient awareness and acceptance represent vital components of the program’s success. The hospital has initiated educational campaigns to inform patients about the benefits and limitations of pharmacogenetic testing. “We encourage patients to discuss this option with their healthcare providers,” Dr. Kumar added. “Personalized medicine is the future, and genetic testing is a fundamental step toward safer, more effective treatments.”
Experts in the medical community have welcomed the development. Dr. Meera Srinivasan, a pharmacologist not associated with the hospital, remarked, “Incorporating genetic insights into prescribing practices can substantially reduce trial-and-error approaches, ultimately improving patient care and reducing healthcare costs.”
While the technology holds promise, challenges remain, including ensuring the accuracy of test interpretation and integrating results into clinical workflows. The hospital plans to provide training for healthcare professionals to adeptly use genetic information in therapeutic decisions.
This initiative aligns with global trends emphasizing personalized healthcare and reflects India’s growing capacity in genomic medicine. By making genetic testing more accessible, the Hyderabad hospital is spearheading progress toward individualized treatment strategies that promise enhanced patient outcomes and minimized medication-related risks.
In summary, the launch of genetic testing services at a Hyderabad hospital represents a significant advance in personalized medicine. By analyzing patients’ genetic profiles, doctors can better determine suitable medications, marking a step forward in precision healthcare tailored to individual needs.
